Author:
Kulatunga D. Chanuka M.,Ranaraja Umanthi,Kim Eun Young,Kim Ryoung Eun,Kim Dong Ern,Ji Kuk Bin,Kim Min Kyu
Abstract
AbstractSH-SY5Y, a neuroblastoma cell line, can be converted into mature neuronal phenotypes, characterized by the expression of mature neuronal and neurotransmitter markers. However, the mature phenotypes described across multiple studies appear inconsistent. As this cell line expresses common neuronal markers after a simple induction, there is a high chance of misinterpreting its maturity. Therefore, sole reliance on common neuronal markers is presumably inadequate. The Alzheimer's disease (AD) central gene, amyloid precursor protein (APP), has shown contrasting transcript variant dynamics in various cell types. We differentiated SH-SY5Y cells into mature neuron-like cells using a concise protocol and observed the upregulation of total APP throughout differentiation. However, APP transcript variant-1 was upregulated only during the early to middle stages of differentiation and declined in later stages. We identified the maturity state where this post-transcriptional shift occurs, terming it "true maturity." At this stage, we observed a predominant expression of mature neuronal and cholinergic markers, along with a distinct APP variant pattern. Our findings emphasize the necessity of using a differentiation state-sensitive marker system to precisely characterize SH-SY5Y differentiation. Moreover, this study offers an APP-guided, alternative neuronal marker system to enhance the accuracy of the conventional markers.
Funder
Korea Health Technology R&D Project administered through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health and Welfare
Publisher
Springer Science and Business Media LLC
Reference55 articles.
1. Biedler, J. L., Roffler-Tarlov, S., Schachner, M. & Freedman, L. S. Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res. 38, 3751–3757 (1978).
2. Xicoy, H., Wieringa, B. & Martens, G. J. The SH-SY5Y cell line in Parkinson’s disease research: A systematic review. Mol. Neurodegener. 12, 10 (2017).
3. Lopes, F. M. et al. Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson’s disease studies. Brain Res. 1337, 85–94 (2010).
4. Hashemi, S. H., Li, J.-Y., Ahlman, H. & Dahlström, A. SSR2(a) receptor expression and adrenergic/cholinergic characteristics in differentiated SH-SY5Y cells. Neurochem. Res. 28, 449–460 (2003).
5. Wu, H. et al. Retinoic acid-induced upregulation of miR-219 promotes the differentiation of embryonic stem cells into neural cells. Cell Death Dis. 8, e2953 (2017).